Last week individuals from across the country, including a group of passionate young advocates, traveled to Washington, D.C., to take part in the Celiac Disease Foundation’s 2025 Advocacy Summit and Hill…
Continue ReadingThe ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingFor those living with celiac disease, every meal comes with a question: Is this truly safe to eat? While the gluten-free diet is the only available treatment, researchers are working…
Continue ReadingThe recent FDA clearance of the GlutenID genetic test has sparked discussion about its role in celiac disease screening. Celiac disease has a strong genetic component, and screening is generally recommended for…
Continue ReadingCODEX issues call for Expert Advisors, New Data to Support Food Labeling Standards for Gluten For individuals with celiac disease, the definition of “gluten-free” isn’t just a label – it’s…
Continue ReadingThe Center for Celiac Research and Treatment at Mass General for Children (MGfC) has appointed Maureen Leonard, MD, MMSc as its new director. Dr. Leonard, who previously served as the…
Continue ReadingCeliac Disease Foundation Showcases Research and Advocacy at AOECS 2024 Reinforcing our commitment to advancing celiac disease research, education, and advocacy on…
Continue ReadingThe Celiac Disease Foundation proudly demonstrated its global leadership in the celiac disease community and commitment to global partnerships at the first ever Latin American Society for the Study…
Continue ReadingThe Celiac Disease Foundation was proud to participate in the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Annual Meeting in November 2024 in Florida, marking a historic…
Continue ReadingPatients with celiac disease (CeD) face a higher risk for some gastrointestinal (GI) cancers than the general population, according to a new study published in the journal Clinical Gastroenterology and Hepatology.…
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO of...